Costs and Cost Drivers of Providing Option B+ Services to Mother-Baby Pairs for PMTCT of HIV in Health Centre IV Facilities in Jinja District, Uganda
Table 4
Cost drivers, mean cost, and percent contribution to total costs of Option B+ services per health facility.
Cost drivers
Mean year 1 costs
Mean year 2 costs
Total 2-year cost
Mean cost per mother-babypair
Mean percent contribution (range) %
Personnel
Facility personnel
2,711.8
2,774.1
5,485.9
36.5
8.2 (7.7–11.6)
Medications
ART (TDF+3TC+EFV)
20,589.4
21,062.6
41,652.0
276.8
62.6 (56.0–65.5)
Nevirapine syrup
195.4
199.9
395.3
2.6
0.6 (0.5–0.6)
Cotrimoxazole
1,820.6
1,862.5
3,683.1
24.5
5.5 (49–5.8)
Laboratory testing
HIV enzyme immunoassay (EIA) tests
402.2
411.5
813.7
5.4
1.2 (1.1–1.3)
CD4 counts
1,204.0
1,231.7
2,435.7
16.2
3.7 (3.3–3.8)
1st HIV DNA PCR
1,710.0
1,749.3
3,459.3
23.0
5.2 (2.2–6.7)
2nd HIV DNA PCR
—
337.5
337.5
2.2
0.5 (NA)
DBS sample transportation for HIV DNA PCR testing
593.8
607.4
1,201.2
8.0
1.8 (1.6–1.9)
Above-site coordination, supervision, and training
MOH
104.4
106.8
211.2
1.4
0.3 (0.2–0.3)
TASO
1,155.4
1,181.9
2,337.3
15.5
3.5 (3.2–3.9)
Option B+ training
135.3
138.4
273.8
1.8
0.4 (0.2–0.4)
Facility-level monitoring and quality improvement
1,973.6
2,019.0
3,992.5
26.5
6.0 (3.2–12.3)
Overheads
115.7
118.4
234.2
1.6
0.4 (0.2–0.7)
Grand total
32,711.7
33,801.0
66,512.7
441.9
100.0%
All costs are in 2014 USD. Cost incurred in the second year (2015) were inflated by the ratio of 2015 and 2014 USA GDP implicit price deflator. SUSTAIN supported transportation of DBS samples.
